This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Brazilian Society of Endocrinology and Metabolism | |
|---|---|
| Name | Brazilian Society of Endocrinology and Metabolism |
| Native name | Sociedade Brasileira de Endocrinologia e Metabologia |
| Formation | 1955 |
| Type | Professional association |
| Headquarters | Rio de Janeiro |
| Region | Brazil |
| Language | Portuguese |
Brazilian Society of Endocrinology and Metabolism is a professional association representing physicians and researchers in the fields of Endocrinology, Metabolism, and related clinical specialties in Brazil. It functions as a national forum linking academic centers such as the University of São Paulo, the Federal University of Rio de Janeiro, and the State University of Campinas with public health institutions like the Ministry of Health (Brazil), regional medical councils such as the Federal Council of Medicine (Brazil), and international bodies including the Endocrine Society (United States), the International Diabetes Federation, and the World Health Organization. The society interfaces with hospitals such as the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, research institutes including the Butantan Institute and the Fiocruz, and educational organizations like the Brazilian Medical Association.
Founded in 1955, the society emerged amid postwar expansions in Brazilian medical education led by figures from the University of São Paulo, the Federal University of Rio de Janeiro, and the Catholic University of Rio Grande do Sul. Early leaders had professional ties to international meetings such as the International Congress of Endocrinology and collaborations with centers like the Massachusetts General Hospital, the Mayo Clinic, and the Karolinska Institute. Through the decades, the society engaged in national debates involving the Ministry of Health (Brazil), regional health secretariats in São Paulo (state), Rio de Janeiro (state), and Minas Gerais, and regulatory frameworks overseen by the Brazilian Health Regulatory Agency (Anvisa). The organization expanded alongside epidemiological shifts documented by institutions like the Oswaldo Cruz Foundation and the Pan American Health Organization.
The society's mission aligns with principles promoted by the World Health Organization and the Pan American Health Organization to improve endocrine care, influence policy at the Ministry of Health (Brazil), and foster education in partnership with universities such as the University of São Paulo and the Federal University of Rio Grande do Sul. Governance includes an executive board, scientific committees, and regional chapters modeled after professional bodies like the Brazilian Medical Association and international counterparts such as the European Society of Endocrinology and the Endocrine Society (United States). The society maintains liaison relationships with specialty organizations including the Brazilian Diabetes Society, the Latin American Thyroid Society, and the International Osteoporosis Foundation.
Membership categories mirror standards used by the American Board of Internal Medicine and by national medical councils such as the Federal Council of Medicine (Brazil), encompassing clinicians trained at institutions like the Federal University of Minas Gerais, researchers affiliated with the National Council for Scientific and Technological Development (CNPq), and trainees enrolled in residency programs accredited by the Brazilian Medical Association. Certification pathways coordinate with residency oversight bodies and with postgraduate programs at universities including the University of São Paulo and the State University of Campinas, and draw on credentialing precedents from the European Board of Endocrinology.
The society runs clinical practice initiatives, public awareness campaigns against noncommunicable diseases in coordination with the Ministry of Health (Brazil) and the Pan American Health Organization, and professional development programs in partnership with tertiary centers such as the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo and research institutes including the Fiocruz. Programs address endocrine disorders prevalent in Brazil, collaborating with the Brazilian Diabetes Society, the Brazilian Society of Pediatrics, and the Brazilian Society of Geriatrics and Gerontology. The society also liaises with patient advocacy groups and healthcare networks operating in metropolitan areas like São Paulo and Rio de Janeiro and with regional universities such as the Federal University of Ceará.
The society publishes clinical practice guidelines and position statements informed by evidence syntheses and by comparative guidance from the Endocrine Society (United States), the European Society of Endocrinology, and the International Diabetes Federation. It issues peer-reviewed material through journals and bulletins that engage authors from institutions such as the University of São Paulo, the Butantan Institute, the Oswaldo Cruz Foundation (Fiocruz), and the State University of Campinas. Guidelines address conditions like diabetes mellitus, thyroid disease, adrenal disorders, and osteoporosis and reference epidemiological data from the Brazilian Institute of Geography and Statistics and public health surveillance coordinated with the Ministry of Health (Brazil).
Annual scientific meetings bring together clinicians and researchers from centers such as the University of São Paulo, the Federal University of Rio de Janeiro, the State University of Campinas, and international delegations from the Endocrine Society (United States), the European Society of Endocrinology, and the International Diabetes Federation. The society offers continuing medical education accredited similarly to programs of the Brazilian Medical Association and collaborates with universities like the Federal University of Rio Grande do Sul to host workshops, symposia, and courses on topics ranging from diabetes technology to thyroid oncology. Meetings attract faculty affiliated with hospitals including the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo and research institutes such as the Fiocruz.
Research priorities align with national health strategies promoted by the Ministry of Health (Brazil) and funding bodies like the National Council for Scientific and Technological Development (CNPq) and the Brazilian Funding Agency for Studies and Projects (FINEP), and collaborate with universities including the University of São Paulo, the State University of Campinas, and the Federal University of Pernambuco. Public health initiatives address diabetes prevalence, thyroid disease, and obesity in partnership with the Pan American Health Organization, the Oswaldo Cruz Foundation, and municipal health secretariats in São Paulo (city), Rio de Janeiro (city), and Salvador, Bahia. Multicenter research networks link sites such as the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo and the Butantan Institute to international consortia supported by the World Health Organization and the International Diabetes Federation.
Category:Medical associations based in Brazil Category:Endocrinology organizations